Cargando…
Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator’s product
BACKGROUND: Existence of anti-malarial generic drugs with low bioavailability marketed on sub-Saharan Africa raises a concern on patients achieving therapeutic concentrations after intake of such products. This work compared bioavailability of one generic tablet formulation with innovator’s product....
Autores principales: | Minzi, Omary MS, Marealle, Ignace A, Shekalaghe, Seif, Juma, Omar, Ngaimisi, Eliford, Chemba, Mwajuma, Rutaihwa, Mastidia, Abdulla, Salim, Sasi, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669611/ https://www.ncbi.nlm.nih.gov/pubmed/23718725 http://dx.doi.org/10.1186/1475-2875-12-174 |
Ejemplares similares
-
Comparison of malaria treatment outcome of generic and innovator’s anti-malarial drugs containing artemether–lumefantrine combination in the management of uncomplicated malaria amongst Tanzanian children
por: Kilonzi, Manase, et al.
Publicado: (2019) -
The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children
por: Sugiarto, Sri Riyati, et al.
Publicado: (2022) -
Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania
por: Kilonzi, Manase, et al.
Publicado: (2020) -
The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment
por: Maganda, Betty A, et al.
Publicado: (2015) -
Adherence to artemether-lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania
por: Minzi, Omary, et al.
Publicado: (2014)